Genetic testing and clinical management practices for variants in non-BRCA1/2 breast (and/or ovarian) cancer susceptibility genes: An international survey by the Enigma Clinical Working Group.

Authors

null

Sarah Nielsen

The University of Chicago Medical Center, Chicago, IL

Sarah Nielsen , Arcangela De Nicolo , Diana Eccles , Iris L Romero , Susan M. Domchek , Alvaro Monteiro , David Goldgar , Amanda Spurdle , Encarna Gomez Garcia

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2018 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Cancer Prevention, Hereditary Genetics, and Epidemiology

Track

Prevention, Risk Reduction, and Genetics

Sub Track

Cancer Genetics

Citation

J Clin Oncol 36, 2018 (suppl; abstr 1539)

DOI

10.1200/JCO.2018.36.15_suppl.1539

Abstract #

1539

Poster Bd #

110

Abstract Disclosures

Similar Posters

Poster

2017 ASCO Annual Meeting

Expanded yield of multiplex panel testing in fully accrued prospective trial.

Expanded yield of multiplex panel testing in fully accrued prospective trial.

First Author: Gregory Idos

Poster

2016 ASCO Annual Meeting

Next-generation sequencing in <i>BRCA1/2</i>-negative breast and ovarian cancer families.

Next-generation sequencing in BRCA1/2-negative breast and ovarian cancer families.

First Author: Jan Hauke

First Author: Michael Francis Walsh

First Author: Nicole Casasanta